|
Cerebricon Announces changes to Contact Details
December 12th, 2009 Kuopio, Finland; Wilmington MA, USA:
Changes to Cerebricon Contact Details
Cerebricon – new member of the Charles River family – announces that it will be changing its contact details for North America and the UK. Contact can now be made through Charles River client Services telephone numbers.
New contact details can be found here:
http://www.cerebricon.com/DowebEasyCMS/?Page=Contact
at this time e-mail enquiries remain the same as well as the contact details for the main offices and laboratories. All enquiries should ideally still go through these numbers. However, prospective clients may contact either of the numbers above should they wish to speak to a Charles River representative regarding the products and services in the area of discovery and imaging askcharlesriver@crl.com.
|
|
|
|
| |
 |
News:
|
|
|
7.6.2010
Charles River to Exhibit at the FELASA Helsinki, Finland June 14th-17th, 2010
|
7.6.2010
Meet Us at This Year’s FENS – 7th FORUM OF EUROPEAN NEUROSCIENCES
|
11.12.2009
Cerebricon Announces changes to Contact Details
|
2.9.2009
Cerebricon to Exhibit at the SFN 39th Annual Meeting in Chicago IL.
|
26.8.2009
Cerebricon Ltd Becomes Part of the Charles River Laboratories Family
|
20.4.2009
Kuopio, Finland; London, UK: Cerebricon Ltd. Announces the Release of 3 Experimental Autoimmune Encephalomyelitis (EAE) Mouse Models for the in vivo Study of Multiple Sclerosis (MS)
|
9.2.2009
Kuopio, Finland; London, UK: Cerebricon Ltd. Announces Exclusive License Agreement With University College London
|
30.1.2009
Kuopio, Finland: Cerebricon to Exhibit at the International Conference on AD/PD 2009 in Prague, Czech Republic
|
29.10.2008
Kuopio, Finland: Cerebricon to Exhibit at the SFN 38th Annual Meeting in Washington, DC.
|
19.9.2008
Kuopio, Finland: Cerebricon to officially launch proprietal preclinical imaging platform
|
19.6.2008
Kuopio, Finland; London, UK: Cerebricon Ltd. proudly commissions new proprietary 7.0 Tesla MRI
|
22.5.2008
Kuopio, Finland: Cerebricon to Exhibit at the International Conference on Alzheimer's Disease 2008 in Chicago
|
4.4.2008
Kuopio, Finland; London, UK: Cerebricon and Medestea publish pre-clinical efficacy data for IAC in a model of stroke in the rat
|
|
|
|
| |
|
|